Yahoo
Canadian Sec - Delayed Quote CAD

Rocket Doctor AI Inc. (AIDR.CN)

0.4400 -0.0200 (-4.35%)
At close: October 30 at 3:56:17 PM EDT
Chart Range Bar
Loading chart for AIDR.CN
  • Previous Close 0.4600
  • Open 0.4500
  • Bid 0.4400 x --
  • Ask 0.4600 x --
  • Day's Range 0.4350 - 0.4500
  • 52 Week Range 0.4350 - 0.9800
  • Volume 47,546
  • Avg. Volume 93,067
  • Market Cap (intraday) 44.681M
  • Beta (5Y Monthly) -0.25
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2700
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 1.26

Rocket Doctor AI Inc. provides personalized health care information services in Canada and United States. The company develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management. It also offers a digital health app, an assessment tool which provides insights about health. In addition, the company provides medical education, medical clinic, and clinical advisor solutions; and offers healthcare information resource. Rocket Doctor AI Inc. was formerly known as Treatment.com AI Inc. and changed its name to Rocket Doctor AI Inc. in August 2025. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.

www.treatment.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

AIDR.CN
37.14%
S&P/TSX Composite index (^GSPTSE)
11.78%

1-Year Return

AIDR.CN
49.43%
S&P/TSX Composite index (^GSPTSE)
18.03%

3-Year Return

AIDR.CN
12.00%
S&P/TSX Composite index (^GSPTSE)
88.90%

5-Year Return

AIDR.CN
98.23%
S&P/TSX Composite index (^GSPTSE)
69.32%

Analyst Insights

View More

Analyst Price Targets

1.26
1.26 Average
0.4400 Current
1.26 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -221.31%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    38.14k

  • Net Income Avi to Common (ttm)

    -2.01M

  • Diluted EPS (ttm)

    -0.2700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.3M

  • Total Debt/Equity (mrq)

    46.41%

  • Levered Free Cash Flow (ttm)

    -1.01M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: